查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948180

全球內部神經調控設備市場：機會與策略展望（至2034年）

Internal Neuromodulation Devices Global Market Opportunities And Strategies To 2034
出版日期: | 出版商: The Business Research Company | 英文 377 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

全球內部神經調節設備市場預計到2024年將達到約25.946億美元，自2019年以來以6.3%的複合年成長率成長。預計該市場將從2024年的25.946億美元成長到2029年的40.466億美元，成長率為9.3%，然後從2029年起繼續以8.1%的複合年成長率成長，到2034年達到59.667億美元。

植入式神經調控裝置是植入式醫療設備，旨在向特定神經、脊髓通路或腦區輸送靶向電刺激或化學刺激，以調節異常的神經活動。這些裝置植入體內用於治療慢性疼痛、運動障礙、癲癇以及其他神經或生理疾病。植入式神經調控裝置的主要目的是恢復或調節那些對傳統治療方法反應不佳的患者的神經功能。

慢性疼痛疾病呈上升趨勢

從歷史上看，體內神經調控設備市場的發展一直受到慢性疼痛疾病日益普遍的推動。隨著慢性疼痛的蔓延，長期藥物治療的限制（例如療效遞減、副作用和藥物依賴性等問題）促使醫療專業人員和患者尋求永續的、基於設備的治療方案。體內神經調控系統，特別是脊髓刺激設備，因其能夠為慢性疼痛患者提供靶向性強、可調節且持久的治療效果而備受關注。例如，根據美國疾病管制與預防中心（CDC）下屬的國家衛生統計中心於2024年11月發布的《2023年全國健康調查》，24.3%的美國成年人（約佔四分之一）在過去三個月內經歷過慢性疼痛，其中8.5%的人報告稱患有嚴重的慢性疼痛，且疼痛經常限制其日常生活或工作。報告顯示，慢性疼痛盛行率從2019年的20.4%上升至7.4%，高影響慢性疼痛盛行率也呈現上升趨勢，凸顯了慢性疼痛疾病負擔的日益惡化。因此，慢性疼痛疾病盛行率的上升正在推動體內神經調節設備市場的擴張。

專注於用於治療癲癇和新興適應症的MRI相容型VNS平台

內部神經調控設備市場的主要企業正日益專注於開發和推出可植入式迷走神經刺激（VNS）系統，這些系統兼容磁振造影（MRI），並核准用於除癲癇和憂鬱症傳統療法之外的新治療適應症。這一趨勢旨在透過在需要時安全地進行MRI影像檢查，以及將VNS的應用範圍擴展到慢性神經系統疾病和發炎性疾病，使VNS療法更加人性化。例如，2025年8月，總部位於美國的生物電子療法開發商SetPoint Medical獲得了美國食品藥物管理局（FDA）對其新開發的可植入式VNS設備SetPoint食品藥物管理局的批准，用於治療對常規治療方法核准的中重度類風濕性關節炎（RA）成人患者。這標誌著VNS的臨床應用範圍顯著擴展到神經系統疾病之外。這表明VNS技術不僅在硬體（可植入且相容MRI）方面不斷發展，而且在治療領域也在不斷拓展，凸顯了將神經調控技術應用於神經系統疾病以外的慢性疾病管理的趨勢。

全球內部神經調節設備市場相對分散，眾多小規模企業參與其中，到 2024 年，前 10主要企業將佔 34.2% 的市場佔有率。

目錄

第1章執行摘要

第2章 目錄

第3章表格一覽

第4章圖表一覽

第5章 報告結構

第6章 市場特徵

  • 一般市場定義
  • 概述
  • 內部神經調控設備市場定義與細分
  • 按類型分類的市場細分
    • 脊髓刺激設備
    • 深部腦部刺激裝置
    • 薦骨神經刺激器
    • 迷走神經刺激設備
    • 胃神經刺激設備
  • 市場區隔：依生物材料分類
    • 金屬生物材料
    • 高分子生物材料
    • 陶瓷生物材料
  • 市場區隔：按應用
    • 腰椎手術後症候群
    • 帕金森氏症
    • 尿失禁
    • 癲癇
    • 胃輕癱
  • 市場區隔：依最終用戶分類
    • 醫院
    • 診所
    • 居家醫療
    • 社區醫學

第7章：主要市場趨勢

  • 專注於用於治療癲癇和新興適應症的MRI相容型VNS平台
  • 開發用於治療尿失禁的全植入式無線骶神經調節系統
  • 擴展封閉回路型與人工智慧賦能的體內神經調節系統
  • 整合定向電極以實現運動障礙的精準神經調控
  • 植入式胃刺激療法在藥物難治性胃輕癱的應用

第8章 全球內部神經調控設備成長分析及策略分析框架

  • 全球內部神經調節設備PESTEL分析（政治、社會、技術、環境與法律因素）
    • 政治因素
    • 經濟
    • 社會的
    • 技術的
    • 環境因素
    • 合法的
  • B2B市場的最終用戶
    • 醫院
    • 診所
    • 居家醫療
    • 社區醫學
  • 全球內部神經調控設備市場規模及成長分析
  • 2019-2024年市場成長表現
    • 2019-2024年市場促進因素
    • 2019-2024年市場限制因素
  • 市場成長預測，2024-2029年，2034年預測
  • 預計成長要素/驅動力
    • 定量成長要素
    • 促進要素
    • 抑制因素
  • 全球內部神經調控設備潛在市場規模（TAM）
    • TAM比較分析

9. 全球內部神經調控設備市場：細分

  • 全球內部神經調控設備市場：依類型、性能及預測分類，2019-2024年、2029年預測、2034年預測
  • 全球內部神經調控設備市場：依生物材料、性能及預測分類，2019-2024年、2029年預測、2034年預測
  • 全球內部神經調控設備市場：依應用、效能及預測分類，2019-2024年、2029年預測、2034年預測
  • 全球內部神經調控設備市場：依最終用戶分類，實際數據及預測數據，2019-2024年、2029年預測值、2034年預測值
  • 全球內部神經調控設備市場：脊髓刺激設備，依類型、表現及預測細分，2019-2024年、2029年預測、2034年預測
  • 全球內部神經調控設備市場：深部腦部刺激設備，依類型、表現及預測細分，2019-2024年、2029年預測、2034年預測
  • 全球體內神經調控設備市場：薦骨神經刺激器，依類型、表現及預測細分，2019-2024年、2029年預測、2034年預測
  • 全球體內神經調控設備市場：迷走神經刺激設備，依類型、表現及預測細分，2019-2024年、2029年預測、2034年預測
  • 全球內部神經調控設備市場：胃神經神經刺激設備，依類型、表現及預測細分，2019-2024年、2029年預測、2034年預測

第10章 內部神經調控設備市場：區域與國家分析

  • 全球內部神經調控設備市場：區域表現及預測（2019-2024年、2029年預測、2034年預測）
  • 全球內部神經調控設備市場：依國家/地區、效能和預測分類，2019-2024 年、2029 年預測、2034 年預測

第11章 亞太市場

第12章 西歐市場

第13章 東歐市場

第14章 北美市場

第15章：南美市場

第16章 中東市場

第17章：非洲市場

第18章：競爭格局與公司概況

  • 公司簡介
  • Medtronic Inc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova plc
  • Nevro Corp

第19章：其他領先和創新企業

  • Axonics Inc.
  • NeuroPace Inc.
  • Biotronik SE & Co. KG
  • Beijing PINS Medical（PINS）
  • ONWARD Medical NV
  • Mainstay Medical International plc
  • Inspire Medical Systems Inc.
  • Synchron Inc.
  • Stimwave Technologies Incorporated
  • Blackrock Neurotech
  • INBRAIN Neuroelectronics（Inbrain）
  • Nuvectra Corporation
  • Aleva Neurotherapeutics SA
  • Second Sight Medical Products Inc.
  • Synapse Biomedical Inc.

第20章：競爭標竿分析

第21章 競爭格局分析

第22章 重大併購

  • Globus Medical Acquired Nevro Corp.
  • Boston Scientific Acquired Axonics Inc.

第23章：植入式神經調控裝置的最新趨勢

  • 用於治療帕金森氏症的自適應封閉回路型深部腦部刺激裝置獲得監管部門核准
  • 自動化程式設計平台核准簡化SCS管理

第24章：機遇與策略

  • 2029年全球內部神經調控設備市場：蘊藏新機會的國家
  • 2029年全球內部神經調控設備市場：新興細分市場機會
  • 2029年全球內部神經調控設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第25章 內部神經調控設備市場：結論與建議

  • 結論
  • 建議

第26章附錄

簡介目錄
Product Code: ME3MINDE01_O25Q4

Internal neuromodulation devices are implantable medical devices designed to deliver targeted electrical or chemical stimulation to specific nerves, spinal pathways, or brain regions, thereby modulating abnormal neural activity. These devices are placed inside the body to treat chronic pain, movement disorders, epilepsy, and other neurological or physiological conditions. The primary purpose of internal neuromodulation devices is to restore or regulate neural function in patients with conditions that do not respond adequately to conventional therapies.

The global internal neuromodulation devices market reached a value of nearly $2,594.6 million in 2024, having grown at a compound annual growth rate (CAGR) of 6.3% since 2019. The market is expected to grow from $2,594.6 million in 2024 to $4,046.6 million in 2029 at a rate of 9.3%. The market is then expected to grow at a CAGR of 8.1% from 2029 and reach $5,966.7 million in 2034.

Rising Prevalence Of Chronic Pain Disorders

During the historic period, the internal neuromodulation devices market was driven by the rising prevalence of chronic pain disorders. As chronic pain became more widespread, limitations of long-term pharmacological management, including declining effectiveness, side effects, and dependency concerns, pushed clinicians and patients to seek durable, device-based solutions. Internal neuromodulation systems, particularly spinal cord stimulators, gained traction as they offered targeted, adjustable, and sustained therapeutic effects for individuals living with persistent pain. For instance, in November 2024, according to the US Centers for Disease Control and Prevention (CDC), a US-based National Center for Health Statistics, in 2023 National Health Interview Survey, 24.3% of US adults (about 1 in 4) reported chronic pain in the past 3 months and 8.5% reported high-impact chronic pain that frequently limited life or work activities. The same report noted that this represented an increase from 20.4% with chronic pain and 7.4% with high-impact chronic pain in 2019, illustrating a rising burden of chronic pain disorders over time Therefore, the internal neuromodulation devices market was driven by the rising prevalence of chronic pain disorders.

Focus On MRI-Compatible VNS Platforms For Epilepsy And New Indications

Major companies in the internal neuromodulation devices market are increasingly emphasizing the development and regulatory introduction of implantable Vagus Nerve Stimulation System (VNS) platforms that are MRI (magnetic resonance imaging)-compatible and cleared for newer therapeutic indications beyond classic epilepsy or depression. This trend aims to make VNS therapy more patient-friendly, by enabling safe access to MRI imaging when needed, and by expanding the use of VNS for chronic neurological or inflammatory diseases. For example, in August 2025, SetPoint Medical, a US-based company develops bioelectronic therapies, newly developed implantable VNS device, SetPoint System, was approved by the US Food and Drug Administration (FDA) for use in adults with moderate-to-severe Rheumatoid Arthritis (RA) who had failed conventional therapies. This represents a meaningful expansion of clinical use for VNS beyond neurological disorders. This shows how VNS technology is evolving, not just on the hardware front (implantable, MRI-compatible), but also in therapeutic positioning, aligning neuromodulation with chronic disease management beyond neurology.

The global internal neuromodulation devices market is fairly fragmented, with large number of small players operating in the market. The top ten competitors in the market made up to 34.2% of the total market in 2024.

Internal Neuromodulation Devices Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global internal neuromodulation devices market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for internal neuromodulation devices? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The internal neuromodulation devices market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider internal neuromodulation devices market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics: - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by biomaterial, by application and by end-user.
  • Key Trends: - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework: - Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Global Market Size And Growth: - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis: - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation: - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by biomaterial, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth: - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies: - Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard: - Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments: - Information on recent developments in the market covered in the report
  • Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations This section includes recommendations for internal neuromodulation devices providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix: - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: Spinal Cord Stimulator; Deep Brain Stimulator; Sacral Nerve Stimulator; Vagus Nerve Stimulator; Gastric Neuro Stimulator
  • 2) By Biomaterial: Metallic Biomaterials; Polymeric Biomaterials; Ceramic Biomaterials
  • 3) By Application: Failed Back Surgery Syndrome; Parkinson's Disease; Urinary Incontinence; Epilepsy; Gastroparesis
  • 4) By End-User: Hospitals; Clinics; Home Healthcare; Community Healthcare
  • Companies Mentioned: Medtronic plc; Abbott Laboratoriesl; Boston Scientific Corporation; LivaNova plc; Nevro Corp
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; internal neuromodulation devices comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes."

Table of Contents

1 Executive Summary

  • 1.1 Internal Neuromodulation Devices - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Internal Neuromodulation Devices Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Spinal Cord Stimulator
    • 6.4.2 Deep Brain Stimulator
    • 6.4.3 Sacral Nerve Stimulator
    • 6.4.4 Vagus Nerve Stimulator
    • 6.4.5 Gastric Neuro Stimulator
  • 6.5 Market Segmentation By Biomaterial
    • 6.5.1 Metallic Biomaterials
    • 6.5.2 Polymeric Biomaterials
    • 6.5.3 Ceramic Biomaterials
  • 6.6 Market Segmentation By Application
    • 6.6.1 Failed Back Surgery Syndrome
    • 6.6.2 Parkinson's Disease
    • 6.6.3 Urinary Incontinence
    • 6.6.4 Epilepsy
    • 6.6.5 Gastroparesis
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Hospitals
    • 6.7.2 Clinics
    • 6.7.3 Home Healthcare
    • 6.7.4 Community Healthcare

7 Major Market Trends

  • 7.1 Focus On MRI-Compatible VNS Platforms For Epilepsy And New Indications
  • 7.2 Development Of Fully Implantable, Wireless SNM Systems For Incontinence Therapy
  • 7.3 Expansion of Closed-Loop and AI-Enabled Internal Neuromodulation Systems
  • 7.4 Integration Of Directional Leads For Precision Neuromodulation In Movement Disorders
  • 7.5 Adoption Of Implantable Gastric Stimulation For Drug-Resistant Gastroparesis

8 Global Internal Neuromodulation Devices Growth Analysis And Strategic Analysis Framework

  • 8.1 Global Internal Neuromodulation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 End Users of B2B Market
    • 8.2.1 Hospitals
    • 8.2.2 Clinics
    • 8.2.3 Home Healthcare
    • 8.2.4 Community Healthcare
  • 8.3 Global Internal Neuromodulation Devices Market Size And Growth Analysis
  • 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Global Internal Neuromodulation Devices Total Addressable Market (TAM)
    • 8.7.1 TAM Comparison Analysis

9 Global Internal Neuromodulation Devices Market Segmentation

  • 9.1 Global Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Internal Neuromodulation Devices Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Internal Neuromodulation Devices Market, Sub-Segmentation Of Spinal Cord Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Internal Neuromodulation Devices Market, Sub-Segmentation By Deep Brain Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.7 Global Internal Neuromodulation Devices Market, Sub-Segmentation By Sacral Nerve Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.8 Global Internal Neuromodulation Devices Market, Sub-Segmentation By Vagus Nerve Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.9 Global Internal Neuromodulation Devices Market, Sub-Segmentation By Gastric Neuro Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Internal Neuromodulation Devices Market, Regional and Country Analysis

  • 10.1 Global Internal Neuromodulation Devices Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Global Internal Neuromodulation Devices Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia Pacific Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia Pacific Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia Pacific Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Asia-Pacific Internal Neuromodulation Devices Market: Country Analysis
  • 11.7 China Market
  • 11.8 Summary
  • 11.9 Market Overview
    • 11.9.1 Country Information
    • 11.9.2 Market Information
    • 11.9.3 Background Information
    • 11.9.4 Government Initiatives
    • 11.9.5 Regulations
    • 11.9.6 Regulatory Bodies
    • 11.9.7 Major Associations
    • 11.9.8 Taxes Levied
    • 11.9.9 Corporate Tax Structure
    • 11.9.10 Major Companies
  • 11.10 China Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 China Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.13 India Market
  • 11.14 India Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 India Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.17 Japan Market
  • 11.18 Summary
  • 11.19 Market Overview
    • 11.19.1 Country Information
    • 11.19.2 Market Information
    • 11.19.3 Background Information
    • 11.19.4 Government Initiatives
    • 11.19.5 Regulations
    • 11.19.6 Regulatory Bodies
    • 11.19.7 Major Associations
    • 11.19.8 Taxes Levied
    • 11.19.9 Corporate Tax Structure
    • 11.19.10 Major Companies
  • 11.20 Japan Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Japan Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.23 Australia Market
  • 11.24 Australia Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Australia Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.27 Indonesia Market
  • 11.28 Indonesia Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 Indonesia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.31 South Korea Market
  • 11.32 Summary
  • 11.33 Market Overview
    • 11.33.1 Country Information
    • 11.33.2 Market Information
    • 11.33.3 Background Information
    • 11.33.4 Government Initiatives
    • 11.33.5 Regulations
    • 11.33.6 Regulatory Bodies
    • 11.33.7 Major Associations
    • 11.33.8 Taxes Levied
    • 11.33.9 Corporate Tax Structure
    • 11.33.10 Investments
    • 11.33.11 Major Companies
  • 11.34 South Korea Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.36 South Korea Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Internal Neuromodulation Devices Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Major companies
  • 13.3 Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Eastern Europe Internal Neuromodulation Devices Market: Country Analysis
  • 13.7 Russia Market
  • 13.8 Russia Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.10 Russia Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Internal Neuromodulation Devices Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Investments
    • 14.15.11 Major Companies
  • 14.16 Canada Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Major Companies
  • 15.3 South America Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 South America Internal Neuromodulation Devices Market: Country Analysis
  • 15.7 Brazil Market
  • 15.8 Brazil Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 Brazil Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Major Companies
  • 16.3 Middle East Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Major Companies
  • 17.3 Africa Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Medtronic Inc
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 Abbott Laboratories
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Business Strategy
    • 18.3.4 Financial Overview
  • 18.4 Boston Scientific Corporation
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Business Strategy
    • 18.4.4 Financial Overview
  • 18.5 LivaNova plc
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 Nevro Corp
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 Axonics Inc.
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 NeuroPace Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Biotronik SE & Co. KG
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 Beijing PINS Medical (PINS)
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 ONWARD Medical NV
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Mainstay Medical International plc
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Inspire Medical Systems Inc.
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 Synchron Inc.
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Stimwave Technologies Incorporated
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Blackrock Neurotech
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 INBRAIN Neuroelectronics (Inbrain)
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 Nuvectra Corporation
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Aleva Neurotherapeutics SA
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 Second Sight Medical Products Inc.
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 Synapse Biomedical Inc.
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Globus Medical Acquired Nevro Corp.
  • 22.2 Boston Scientific Acquired Axonics Inc.

23 Recent Developments In Internal Neuromodulation Devices

  • 23.1 Adaptive Closed-Loop Deep Brain Stimulator Gains Regulatory Approval For Parkinson's Therapy
  • 23.2 Automated Programming Platform Approved To Simplify SCS Management

24 Opportunities And Strategies

  • 24.1 Global Internal Neuromodulation Devices Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Global Internal Neuromodulation Devices Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Global Internal Neuromodulation Devices Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Internal Neuromodulation Devices Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer